ASTRAZENECA PHARMA Surges by 5%; BSE HEALTHCARE Index Up 0.3%
August 8, 2019 09:20 AM

ASTRAZENECA PHARMA share price has zoomed 5% and is presently trading at Rs 1,985.

Meanwhile, the BSE HEALTHCARE Index is at 12,605 (up 0.3%).

Among the top Gainers in the BSE HEALTHCARE Index today is ASTRAZENECA PHARMA (up 5.4%).

DR. REDDYS LAB and J.B.CHEMICALS (down 0.1%) are among the top losers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 1,710 to Rs 1,985, registering a gain of Rs 275 (up 14.4%).

On the other hand, the BSE HEALTHCARE has moved down from 14,551 to 12,605, loss of 1,946 points (down 13.4%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were PROCTER & GAMBLE HEALTH (up 59.6%), DIVIS LABORATORIES (up 40.3%) and APOLLO HOSPITALS (up 35.7%).

What About the Benchmark Indices?

The BSE Sensex is at 36,808 (up 0.3%).

The top gainers among the BSE Sensex stocks today are YES BANK (up 3.1%), HUL (up 2.0%) and TATA MOTORS DVR (up 1.7%). Other gainers include AXIS BANK (up 1.2%) and KOTAK MAHINDRA BANK (up 1.1%). The most traded stocks in the BSE Sensex are HUL and ASIAN PAINTS.

In the meantime, NSE Nifty is at 10,899 (up 0.4%). YES BANK (up 2.8%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 37,666 to 36,808, registering a gain of -858 points (up -2.3%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit down at Rs 98 million for the quarter ended March 2019, compared to a loss of Rs 291 million a year ago. Net Sales declined 11.6% to Rs 1.9 billion during the period as against Rs 2.2 billion in January-March 2018.

For the year ended March 2018, ASTRAZENECA PHARMA reported 29.2% increase in net profit to Rs 259.0 million compared to net profit of Rs 200.0 million during FY17.

Revenue of the company grew 4.3% to Rs 6 billion during FY18.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 89.8x.